Baker Avenue Asset Management, LP Gsk PLC Transaction History

Baker Avenue Asset Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$40.23 - $47.74 $280,362 - $332,700	-6,969 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$38.88 - $45.31 $66,057 - $76,981	1,699 Added 32.24%	6,969 $307,000
Q3 2021 Nov 15, 2021	BUY	$38.79 - $43.16 $204,423 - $227,453	5,270 New	5,270 $201,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $71.4B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Baker Avenue Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Baker Avenue Asset Management, LP with notifications on news.